Stock DNA
Diversified consumer products
INR 1,978 Cr ()
27.00
57
0.00%
0.00
0.00%
3.93
Total Returns (Price + Dividend) 
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Investor Presentation
01-Feb-2026 | Source : BSEInvestor Presentation pursuant to Regulation 30 under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Press Release / Media Release
01-Feb-2026 | Source : BSEPress release for the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 31 2026
31-Jan-2026 | Source : BSEOutcome of the Board Meeting held on January 31 2026 inter-alia for the approval of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31 2025 and other matter as detailed in the enclosed letter.
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 6 Schemes (7.35%)
Held by 13 FIIs (1.36%)
Sidhartha Bhushan Khurana (29.75%)
Icici Prudential Multi-asset Fund (3.46%)
24.58%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 4.67% vs 4.12% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -3.53% vs 4.01% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 10.38% vs 5.98% in Mar 2024
YoY Growth in year ended Mar 2025 is 21.67% vs 72.64% in Mar 2024